Apomorphine Penject – Emerging Evidence and Treatment Strategies for Delayed on and off Periods in Parkinson’s disease

Chairperson:

Olivier Rascol¹

Speakers:

Fabrizio Stocchi,² Stuart Isaacson,³ William Ondo⁴

1. Professor, Toulouse University Hospital Clinical Investigation Centre, Toulouse, France
2. Professor, Institute of Research and Medical Care, IRCCS San Raffaele, Rome, Italy
3. Associate Professor, Florida International University, Herbert Wertheim College School of Medicine, Miami; Director, Parkinson’s Disease and Movement Disorders Center of Boca Raton; Research Director, Marcus Neuroscience Institute, Boca Raton Regional Hospital, Florida, USA
4. Professor, University of Texas Health Science Center, Houston, Texas, USA

Disclosure:

This symposium was sponsored by Britannia Pharmaceuticals Limited.

Acknowledgements:

Writing assistance was provided by Helen Lawn Associates PR Limited.

Support:

The publication of this article was funded by Britannia Pharmaceuticals Limited. The views and opinions expressed are those of the authors and not necessarily of Britannia Pharmaceuticals Limited.

Citation:

EMJ Neurol. 2014;1[1]:27-35. DOI/10.33590/emjneurol/10311874. https://doi.org/10.33590/emjneurol/10311874.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.